Emily Mullin

I am MIT Technology Review’s associate editor for biomedicine, reporting from Washington, D.C. I look for stories about how biotechnology and innovations in medicine are changing our health and livelihoods—and at what cost. I am also interested in the degree to which these advances affect health equity around the world. Previously, I was a contributor at Forbes and an associate editor at FierceBiotech. Get in touch at emily.mullin@technologyreview.com.